Bayer Consumer Health is partnering with “deep-tech” start-up Impli – a firm that is currently developing an implantable hormone-monitoring platform to help women undergoing fertility treatment.
Bayer Consumer Health Backs ‘Implantable Healthcare’ Start-Up Impli
Bayer hopes Impli's implantable hormone biosensor will reveal self-care opportunities in the areas of stress, sleep, weight management, cardiovascular health, women’s health, or bone health.
More from Deals
• By
Alliance shareholders overwhelmingly back takeover by DBAY Advisors after improved offer values UK-based firm at £362m.
• By
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
• By
Cooper takes another step in its international expansion strategy through a partnership with Romania’s MagnaPharm for the distribution and commercialization of its self-care brand portfolio in Central and Eastern Europe (CEE).
• By
The Aurelius-owned distributor will create a new business unit especially for this purpose, headed up by business director Patrik Hene.
More from Digital Technologies
• By
To improve engagement with patient information, a UK ePI Task Force comprising PAGB, ABPI and BGMA is looking at how electronic patient information leaflets (ePILs) can be introduced in the country.
• By
Bayer hopes Impli's implantable hormone biosensor will reveal self-care opportunities in the areas of stress, sleep, weight management, cardiovascular health, women’s health, or bone health.
• By
Cork-based iron supplement manufacturer Solvotrin teams up with app developer Clue to offer consumers a free year's subscription to the latter's menstrual health app.